American Society of Hematology, Blood Advances, 22(3), p. 3674-3687, 2019
DOI: 10.1182/bloodadvances.2018030478
Full text: Download
Key Points Human ILC1-like cells kill tumors in a KIR-independent manner. The cytotoxicity of human ILC1-like cells is impaired in AML at diagnosis but is restored in remission.